Stay updated with breaking news from Valuating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NewAmsterdam Pharma, a clinical-stage company focused on the research and development of transformative oral therapies for metabolic diseases, today announced that it has initiated a Phase 2 dose-finding
Intercept Pharmaceuticals, Inc. announced that REVERSE, a Phase 3 study evaluating the safety and efficacy of OCA in patients with compensated cirrhosis due to nonalcoholic steatohepatitis , did not... | October 1, 2022
U.S. buyout funds KKR and CVC are evaluating buying stakes in Spanish hospital group Quironsalud from Germany's healthcare group Fresenius, news website El Confidencial reported on Friday citing... | September 30, 2022
Evaluation is critical to the EBRD's work. Learn how our Evaluation Department reviews projects and documents lessons learned.
The Company plans to work with the FDA to design a Phase 3 program in moderate-to-high systemic disease activity patients to begin in 2023, ahead of expectations - Horizon Therapeutics plc (Nasdaq: